APR 21, 2020 1:00 PM PDT

New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2

WRITTEN BY: Lawrence Renna

The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the world’s attention. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there is still a considerable need to develop diagnostic tests for the SARS-CoV-2 that are rapid, easy to implement, and more accurate than existing tests. New research, published on April 20, 2020, in the journal ACS Nano details the discovery of a new diagnostic test that uses a field-effect transistor (FET)-based biosensor to detect SARS-CoV-2. This new technology can detect very small concentrations of the virus (concentrations of 1 fg/mL) from samples collected from nasopharyngeal (deep nasal passage) swabs.

A majority of the currently available diagnostic tests for SARS-CoV-2 involve a technique called real-time reverse transcription-polymerase chain reaction (RT-PCR). In RT-PCR, a tiny amount of the virus’ ribonucleic acids (RNA), collected from the patient, are copied millions to billions of times in order to amplify the signal and detect the virus. Unfortunately, this ‘copying’ process typically takes at least 3 hours and requires an additional, time-consuming step to prepare the virus’ RNA for amplification. Thus, rapid detection is not currently possible.

Enter FET-based diagnostic biosensors! FETs are common electrical components used in many different integrated circuits for a variety of applications. Edmond Changkyun Park, Seung Il Kim, and colleagues developed a FET-based biosensor based on a sheet of graphene, with antibodies attached to it, that can instantly and easily detect SARS-CoV-2. Their technique does not require any additional steps to prepare the sample from the patient for testing. The FET-based diagnostic tool works by modulating the electrical signal from the device when the virus binds to the attached antibodies. Their device was highly sensitive to SARS-CoV-2 and did not show any false-positives from other similar viruses such as the Middle East respiratory syndrome-related coronavirus (MERS-CoV). This new diagnostic device would enable instant detection of SARS-CoV-2 in patients. Also, this FET-biosensor can be adapted for the easy and rapid detection of other viruses that already exist or may emerge in the future.

 

 

Sources: American Chemical Society, ACS Nano

About the Author
  • Hello! I am a scientist currently living in Southern California, although I am originally from the east coast. I received my B.S. in Chemistry from Northeastern University in 2012, and my Ph.D. in Chemistry from the University of Massachusetts Amherst. I also had a postdoctoral appointment at the University of California, Irvine. I have written 25+ peer-reviewed articles, several patents, and one book chapter. I am a reviewer for scientific manuscripts, and a freelance editor and writer. Outside of science, I enjoy spending time with my family, training Jiu-Jitsu, and baking sourdough bread. I am happy to be writing for LabRoots.
You May Also Like
APR 20, 2021
Clinical & Molecular DX
Stressed Out Pregnant Mothers More Likely to Have Girls
APR 20, 2021
Stressed Out Pregnant Mothers More Likely to Have Girls
Scientists from the University of Granada used hair samples to monitor cortisol in a cohort of over 100 pregnant women a ...
MAY 03, 2021
Health & Medicine
The Challenges and Advantages of Direct PCR Amplification
MAY 03, 2021
The Challenges and Advantages of Direct PCR Amplification
  Testing for COVID-19 continues to be one of the most important tools in the global fight to slow and reduce the i ...
MAY 20, 2021
Clinical & Molecular DX
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
MAY 20, 2021
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
A UK-based research study has shown that while ovarian cancer screening is beneficial for detecting cancers earlier, it ...
MAY 21, 2021
Neuroscience
New Method to Predict Treatment Outcomes for Epilepsy 95% Accurate
MAY 21, 2021
New Method to Predict Treatment Outcomes for Epilepsy 95% Accurate
Scientists from the University of Nottingham have found that the way neurons are connected within different brain region ...
JUL 13, 2021
Clinical & Molecular DX
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
JUL 13, 2021
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
Researchers have developed the first diagnostic “pen” that acts as a guide for surgeons, helping them distin ...
SEP 16, 2021
Clinical & Molecular DX
Your T-Shirt Could Soon Tell You if Your Heart Is Ok
SEP 16, 2021
Your T-Shirt Could Soon Tell You if Your Heart Is Ok
Forget uncomfortable chest straps or clunky wristbands—thanks to a new innovation in nanotechnology, your t-shirt ...
Loading Comments...